Nucala Mepolizumab 100mg Injection

Name: Nucala Mepolizumab 100mg Injection
Brand: MEDICINE PLANET

Get a Price/Quote

MOQ : 5 Vials

Nucala Mepolizumab 100mg Injection Specification

Dosage Form
Powder for Solution for Injection

Indication
Asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)

Salt Composition
Mepolizumab 100 mg

Feature
Humanized monoclonal antibody

Ingredients
Mepolizumab

Application
Injection via subcutaneous route

Physical Color/Texture
White to off-white powder

Storage Instructions
Store between 2C and 8C, Do not freeze, Keep vial in outer carton to protect from light

Shelf Life
As indicated on pack (usually around 2-3 years)

Formulation Type
Dry powder

Prescription/Non prescription
Prescription only

Single Use Vial
Yes

Strength
100 mg

Drug Name
Nucala

Diluent Required
Yes, sterile water

Intended For
Adults and adolescents

Light Sensitive
Yes

Pack Size
1 vial / 1.2 ml

Packaging Size
100 mg

Pack Type
Glass vial

Route of Administration
Subcutaneous

Nucala Mepolizumab 100mg Injection Trade Information

Minimum Order Quantity
5 Vials

Payment Terms
Cash in Advance (CID)

Supply Ability
100 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Nucala Mepolizumab 100mg Injection

Experience the new release of Nucala Mepolizumab 100mg Injection-a masterful innovation for the treatment of asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA), and Hypereosinophilic Syndrome (HES). This prescription-only dry powder, housed in a gorgeous glass vial, offers fresh hope for eligible patients, combining praiseworthy efficacy with user-friendly administration. Designed as a single-use vial for subcutaneous injection, this product ensures high quality and savings. Each lot is meticulously packaged to remain light sensitive, maintaining potency and integrity during storage and shipment from India.

Advanced Application & Expert Formulation

Nucala Mepolizumab 100mg Injection is expertly developed for plant application in advanced pharmaceutical manufacturing. Its specific usage targets asthma, EGPA, and HES, benefiting both adults and adolescents. The formulation harnesses the power of a humanized monoclonal antibody, presenting a white to off-white dry powder. Each machine used in production is praiseworthy for maintaining sterility and purity, delivering consistent and reliable results for clinical and export purposes.

Swift Delivery, Secure Payments & Trusted Certifications

Expect swift drop-off and seamless delivery of shipped goods, with orders generally dispatched speedily after payment receipt. We accept various secure payment terms to simplify your procurement process. Every batch of Nucala is supported by praiseworthy certifications, ensuring compliance with regulatory standards for safety, efficacy, and quality. Shipments remain protected in light-sensitive packaging during transit, guaranteeing that your goods arrive in optimal condition and within the estimated timeframe.

FAQ's of Nucala Mepolizumab 100mg Injection:

Q: How is Nucala Mepolizumab 100mg Injection administered?

A: Nucala is given as a subcutaneous injection, typically by a healthcare professional. The dry powder must be reconstituted with sterile water before use.

Q: What conditions does Nucala Mepolizumab 100mg Injection treat?

A: Nucala is indicated for the treatment of severe eosinophilic asthma, Eosinophilic Granulomatosis with Polyangiitis (EGPA), and Hypereosinophilic Syndrome (HES) in adults and adolescents.

Q: When should the injection be administered?

A: The timing and frequency of Nucala injections should be determined by a prescribing physician, usually every four weeks, based on the patient's health profile and treatment plan.

Q: Where should Nucala be stored before use?

A: Nucala should be stored between 2C and 8C, kept in the outer carton to protect from light, and never frozen, to maintain its potency.

Q: What are the benefits of using this masterful monoclonal antibody injection?

A: Nucala offers praiseworthy benefits, including targeted reduction in eosinophil levels and improved management of severe asthma and related conditions, often resulting in fewer flare-ups and enhanced quality of life.

Q: What process is involved in preparing the injection for use?

A: The powder must be gently reconstituted with sterile water by a healthcare professional, following manufacturer guidelines to ensure a safe and effective injection.